GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,176,000 | +18.4% | 10,200 | 0.0% | 0.32% | 0.0% |
Q3 2020 | $993,000 | -20.2% | 10,200 | 0.0% | 0.32% | -22.5% |
Q2 2020 | $1,244,000 | +39.3% | 10,200 | 0.0% | 0.41% | +1.7% |
Q1 2020 | $893,000 | -16.2% | 10,200 | 0.0% | 0.41% | +6.0% |
Q4 2019 | $1,066,000 | -53.2% | 10,200 | -48.5% | 0.38% | -63.5% |
Q3 2019 | $2,276,000 | +20.0% | 19,800 | +80.0% | 1.05% | +49.6% |
Q2 2019 | $1,897,000 | -33.0% | 11,000 | -34.5% | 0.70% | -32.8% |
Q1 2019 | $2,831,000 | +286.7% | 16,800 | +75.0% | 1.05% | +130.4% |
Q4 2018 | $732,000 | -42.5% | 9,600 | 0.0% | 0.45% | -25.0% |
Q3 2018 | $1,272,000 | -5.0% | 9,600 | 0.0% | 0.60% | +17.7% |
Q2 2018 | $1,339,000 | +23.8% | 9,600 | 0.0% | 0.51% | +21.8% |
Q1 2018 | $1,082,000 | -14.6% | 9,600 | 0.0% | 0.42% | -5.6% |
Q4 2017 | $1,267,000 | +37.4% | 9,600 | +4.3% | 0.45% | +27.7% |
Q2 2017 | $922,000 | -17.2% | 9,200 | 0.0% | 0.35% | -17.8% |
Q1 2017 | $1,113,000 | +32.8% | 9,200 | +22.7% | 0.43% | +13.0% |
Q4 2016 | $838,000 | – | 7,500 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |